Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03720197 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Registry of Patients Living With Type 1 Diabetes

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary and study completion dates: Mar 31, 2026 to Mar 31, 2027
    • Site details revised at 1 of 7 sites
    • Publications: 2 to 12
    v8
  2. Enrollment target: 12000 to 6000v7 Show 5 more changesShow less
    • Primary and study completion dates: Mar 31, 2024 to Mar 31, 2026
    • Study sites: 6 to 7
    • Interventions: Blood and urine tests (Other), Food questionnaire (Other), List of medications (Other), Online questionnaire - Phase 1 (Other), Online… to Blood and urine tests (Other), Continuous glucose monitor (Other), Food questionnaire (Other), List of medications (Other), Online…
    • Study description expanded, about 38 words
    • Eligibility criteria shortened, about 4 words
  3. Re-verified, no change to tracked fieldsv6
  4. Primary and study completion dates: Mar 31, 2022 to Mar 31, 2024v5
  5. Re-verified, no change to tracked fieldsv4
Show 2 earlier versionsHide 2 earlier versions
  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Apr 15, 2019 to Feb 20, 2019
    • Site details revised at 6 of 6 sites
    v3
  2. Start date: Jan 15, 2019 to Apr 15, 2019v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A registry of individuals with type 1 diabetes open to all patients with type 1 diabetes living in Canada will be established. The objective of this registry will be to measure the frequency and the severity of episodes of hypoglycemia. Participants will be invited to answer questionnaires about the frequency of their hypoglycemic episodes, their fear about hypoglycemia, their symptoms of hypoglycemia, the factors in cause (insulin therapy, nutrition, exercise, etc.), etc. Participation to the registry is divided in 3 phases. The first phase is mandatory for all participants. Phases 2 and 3 are optional.
Trial Details
NCT Number NCT03720197
Lead Sponsor Institut de Recherches Cliniques de Montreal
Conditions
(from sponsor)		 Type 1 Diabetes Mellitus
Related terms Diabetes Mellitus, Type 1
Enrollment 6,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov